Impact of patient characteristics on the clinical efficacy of mongersen (GED‐0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease

por Monteleone, G., Di Sabatino, A., Ardizzone, S., Pallone, F., Usiskin, K., Zhan, X., Rossiter, G., Neurath, M. F.
Publicado 2016

Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer

por Kalimutho, M, Di Cecilia, S, Del Vecchio Blanco, G, Roviello, F, Sileri, P, Cretella, M, Formosa, A, Corso, G, Marrelli, D, Pallone, F, Federici, G, Bernardini, S
Publicado 2011

Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth

por De Simone, V, Franzè, E, Ronchetti, G, Colantoni, A, Fantini, M C, Di Fusco, D, Sica, G S, Sileri, P, MacDonald, T T, Pallone, F, Monteleone, G, Stolfi, C
Publicado 2015

A functional role for Smad7 in sustaining colon cancer cell growth and survival

por Stolfi, C, De Simone, V, Colantoni, A, Franzè, E, Ribichini, E, Fantini, M C, Caruso, R, Monteleone, I, Sica, G S, Sileri, P, MacDonald, T T, Pallone, F, Monteleone, G
Publicado 2014

Frataxin participates to the hypoxia-induced response in tumors

por Guccini, I, Serio, D, Condò, I, Rufini, A, Tomassini, B, Mangiola, A, Maira, G, Anile, C, Fina, D, Pallone, F, Mongiardi, M P, Levi, A, Ventura, N, Testi, R, Malisan, F
Publicado 2011